Drug Shortage Report for DIPYRIDAMOLE INJECTION, USP

Last updated on 2018-09-06 History
Report ID 59148
Drug Identification Number 02244475
Brand name DIPYRIDAMOLE INJECTION, USP
Common or Proper name Dipyridamole Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) DIPYRIDAMOLE
Strength(s) 5MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS
Packaging size 10mL
ATC code B01AC
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-08-24
Actual start date
Estimated end date 2018-09-05
Actual end date 2018-09-05
Shortage status Resolved
Updated date 2018-09-06
Company comments Dipyridamole Injection, USP 5 mg/mL 10 mL Vial will be available at all distribution centers effective today, Wednesday, September 5, 2018.
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2018-09-06 English Compare
v5 2018-09-05 French Compare
v4 2018-09-05 French Compare
v3 2018-09-05 English Compare
v2 2018-08-25 French Compare
v1 2018-08-25 English Compare